ISN’s relations with industry have been increasing over the past years. In 2007, ISN launched a formal Committee of Corporate Members consisting of high level representatives of prominent companies active in the field of nephrology. This collaborative forum provides a platform for the corporate partners to exchange views with our Society and to support the common goal of transparently and appropriately working together to benefit the worldwide renal community.
ISN’s current corporate partners are:
- Abbott
- Amgen
- Baxter
- Fresenius
- Genzyme
- Johnson & Johnson/OrthoBiotech
- Leo Pharmaceuticals
- Roche
- Shire
- Takeda
- Wyeth
Participation in the Corporate Members Committee is by invitation only. For more information on how to become a member or for more detailed information on partnership opportunities please contact Luca Segantini, ISN Executive Director at lsegantini@isn-online.org or Stacey Wilson at swilson@isn-online.org.
